GERD drug Esomeprazole linked with Hyperprolactinaemia, reveals IPC Drug Safety alert - Video
|
Overview
The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of September, has revealed that Esomeprazole, indicated for the treatment of Gastroesophageal reflux disease (GERD), is linked with adverse drug reactions (ADRs) named Hyperprolactinaemia.
In connection to the above, the Indian Pharmacopoeia Commission (IPC) has cautioned healthcare professionals to diligently monitor the potential occurrence of Adverse Drug Reactions (ADRs) when administering Esomeprazole.
For more details, check out the link given below:
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To GERD Drug Esomeprazole
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751